Ortiz-Rubio A, López-Verdín S, Ochoa-Velázquez H

Idioma: Español
Referencias bibliográficas: 30
Paginas: 6-10
Archivo PDF: 172.36 Kb.

RESUMEN

La atención dental debe acompañar a los pacientes que reciben terapia contra el cáncer de cabeza y cuello debido a que existen efectos secundarios relacionados con la radioterapia y un mal estado bucal, así como secuelas por la cirugía ablativa. Los principales efectos desarrollados por la radioterapia incluyen xerostomía y mucositis, seguidos por trismus, caries por radiación y osteorradionecrosis. Para disminuir el riesgo de desarrollar estos padecimientos es necesaria la visita al cirujano dentista previa al tratamiento para realizar los procedimientos bajo los requerimentos de un paciente con cáncer y hacer la toma de decisiones ante dientes cariados, restauraciones extensas, enfermedad periodontal o dientes posteriores inaccesibles para una higiene diaria. Sin embargo, puede ser desafiante llevar a cabo estas tareas en el corto periodo entre el diagnóstico del paciente y el inicio de su tratamiento. De igual manera los pacientes que han terminado el tratamiento deberán ser atendidos con consideraciones especiales por la posibilidad de desarrollar osteorradionecrosis.

REFERENCIAS (EN ESTE ARTÍCULO)

1. Cancer Research UK. [Accessed May 2011] Available in: www.cancerresearchuk.org.

2. Sulaiman F, Huryn JM, Zlotolow IM. Dental extractions in the irradiated head and neck patient: a retrospective analysis of Memorial Sloan-Kettering Cancer Center protocols, criteria and end results. J Oral Maxillofac Surg. 2003; 61 (10): 1123-1131.

3. Moore S, Burke MC, Fenlon MR, Banerjee A. The role of the general dental practitioner in managing the oral care of head and neck oncology patients. Dent Update. 2012; 39: 694-702.

4. National Institute for Clinical Excellence. Improving Outcomes in Head and Neck Cancers. The Manual. London: NICE, 2004.

5. Raber-Durlacher JE, Elad S, Barasch A. Oral mucositis. Oral Oncol. 2010; 46 (6): 452-456.

6. Keefe DM, Schubert MM, Elting LS et al. Updated clinical practice guidelines for the prevention and treatment of mucositis. Cancer. 2007; 109 (5): 820-831.

7. Scottish Intercollegiate Guidelines Network: 90. Diagnosis and Management of Head and Neck Cancer. A National Clinical Guideline, 2006. [Accessed 20th April 2010] Available from: www.sign.ac.uk.

8. Shaw MJ, Kumar NDK, Duggal M et al. Clinical Guidelines. The Oral Management of Oncology Patients requiring Radiotherapy: Chemotherapy: Bone Marrow Transplantation. The Dental Faculty of the Royal College of Surgeons of England, London, 1999.

9. Vissink A, Johannes’s-Gravenmade E, Panders AK, Vermey A. Treatment of hyposalivation. Ear Nose Throat J. 1988; 67 (3): 179-185.

10. Niedermeier W, Matthaeus C, Meyer C et al. Radiation-induced hyposalivation and its treatment with oral pilocarpine. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1998; 86 (5): 541-549.

11. Hahnel S, Behr M, Handel G, Bürgers R. Saliva substitutes for the treatment of radiation-induced xerostomia – a review. Support Care Cancer. 2009; 17: 1331-1343.

12. Porter SR, Fedele S, Habbab KM. Xerostomia in head and neck malignancy. Oral Oncol. 2010; 46: 460-463.

13. Ruo Redda MG, Allis S. Radiotherapy-induced taste impairment. Cancer Treatment Rev. 2006; 32: 541-547.

14. Maes A, Huygh I, Weltens C et al. De Gustibus: time scale of loss and recovery of tastes caused by radiotherapy. Radiother Oncol. 2002; 63: 195-201.

15. Aguiar GP, Jham BC, Magalhães CS, Sensi LG, Freire AR. A review of the biological and clinical aspects of radiation caries. J Contemp Dent Pract. 2009; 10 (4): 83-89.

16. Kielbassa AM, Hinkelbein W, Hellwig E, Meyer-Luckel H. Radiation-related damage to dentition. Lancet Oncol. 2006; 7 (4): 326-335.

17. Bensadoun RJ, Riesenbeck D, Lockhart PB, Elting LS, Spijkervet FK, Brennan MT. A systematic review of trismus induced by cancer therapies in head and neck cancer patients. Support Care Cancer. 2010; 18 (8): 1033-1038.

18. Garnett MJ, Nohl FS, Barclay SC. Management of patients with reduced oral aperture and mandibular hypomobility (trismus) and implications for operative dentistry. Br Dent J. 2008; 204 (3): 125-131.

19. Louise KM, Brennan MT, Noll JL et al. Radiation-induced trismus in head and neck cancer patients. Support Care Cancer. 2008; 16 (3): 305-309.

20. Jolly DE. Osteoradionecrosis, oral health and dental treatment. Dent Assist. 2004; 73: 4-7, quiz 8-9.

21. Makkonen TA, Kiminki A, Makkonen TK, Nordman E. Dental extractions in relation to radiation therapy of 224 patients. Int J Oral Maxillofac Surg. 1987; 16: 56-64.

22. Chrcanovic BR, Reher P, Sousa AA, Harris M. Osteoradionecrosis of the jaws a current overview-Part 2: dental management and therapeutic options for treatment. Oral Maxillofac Surg. 2010; 14 (2): 81-95.

23. Murray CG, Daly TE, Zimmerman SO. The relationship between dental disease and radiation necrosis of the mandible. Oral Surg Oral Med Oral Pathol. 1980; 49: 99-104.

24. Oh HK, Chambers MS, Garden AS, Wong PF, Martin JW. Risk of osteoradionecrosis after extraction of impacted third molars in irradiated head and neck cancer patients. J Oral Maxillofac Surg. 2004; 62: 139-144.

25. Schiødt M, Hermund UN. Management of oral disease prior to radiation therapy. Support Care Cancer. 2002; 10 (1): 40-43.

26. Kluth EV, Jain PR, Stuchell RN, Frich JC Jr. A study of factors contributing to the development of osteoradionecrosis of the jaws. J Prosthet Dent. 1988; 59 (2): 194-201.

27. Marx RE, Johnson RP. Studies in the radiobiology of osteoradionecrosis and their clinical significance. Oral Surg Oral Med Oral Pathol. 1987; 644: 379-390.

28. Epstein JB, Wong FL, Stevenson-Moore P. Osteoradionecrosis: clinical experience and a proposal for classification. J Oral Maxillofac Surg. 1987; 45: 104-110.

29. Coffin F. The incidence and management of osteoradionecrosis of the jaws following head and neck radiotherapy. Br J Radiol. 1983; 56 (671): 851-857.

30. Widmark G, Sagne S, Heikel E. Osteoradionecrosis of the jaws. Int J Oral Maxillofac Surg. 1989; 18: 302-306.